DR Horton’s Stable Valuation Amid Rising Costs and Innovation Challenges
DR Horton’s steady entry‑level home strategy delivers solid cash flow and a P/E of 12, but lagging modular tech and rising material costs may pressure margins as housing demand shifts.
6 minutes to read









